ArticleCancers2018

The Transition between Telomerase and ALT Mechanisms in Hodgkin Lymphoma and Its Predictive Value in Clinical Outcomes.

Radhia M'kacher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.